efficacy of airway clearance therapy (ACT) on short time outcome of cystic fibrosis patients
Not Applicable
- Conditions
- cystic fibrosis.Cystic fibrosis with pulmonary manifestations
- Registration Number
- IRCT20131012014988N3
- Lead Sponsor
- Reasearch Deputy, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
• Patients with CF diagnosis•
Patients aged 5 to 14 years•
Patients with exacerbation of lung disease with FEV1 = 20-70% in initial spirometry when admitted
Exclusion Criteria
• Patients with reluctance to continue participating in the study•
Patients who can not be traced to a cause such as death, transference to another city, etc. during the study period.•
Patients who do not have adequate compilation to continue treatment.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forced expiratory volume in the first second. Timepoint: In the second and last day of the admission. Method of measurement: By using spirometry device.;FEV1/FVC. Timepoint: In the second and last day of the admission. Method of measurement: By using spirometry device.;Peak expiratory flow. Timepoint: In the second and last day of the admission. Method of measurement: By using peak flow-meter device.
- Secondary Outcome Measures
Name Time Method umber of Exacerebration within six months. Timepoint: within six months. Method of measurement: Cheklist.